Literature DB >> 12934182

Pulmonary immunoglobulin responses to Streptococcus pneumoniae are altered but not reduced in human immunodeficiency virus-infected Malawian adults.

Stephen B Gordon1, David E Miller, Richard B Day, Tom Ferry, David S Wilkes, Carol T Schnizlein-Bick, Eduard E Zijlstra, Robert C Read, Malcolm E Molyneux, Homer L Twigg.   

Abstract

We tested the hypothesis that human immunodeficiency virus (HIV)-infected adults have a specific defect in anti-pneumococcal capsular polysaccharide (Pn-specific) immunoglobulin (Ig) in fluid obtained from the lower respiratory tract. Higher levels of total IgG and IgM were present in bronchoalveolar lavage samples from HIV-infected subjects than in those from HIV-uninfected subjects. Pn-specific IgG and IgM in bronchoalveolar lavage samples were not significantly different between HIV-infected and -uninfected subjects. After pneumococcal infection, HIV-infected patients had higher bronchoalveolar lavage levels of Pn-specific IgG than HIV-infected patients without recent infection (geometric means, 387 vs. 30 ng/mL, P=.001).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12934182     DOI: 10.1086/377480

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

Review 1.  Lung microbiome in human immunodeficiency virus infection.

Authors:  Homer L Twigg; George M Weinstock; Kenneth S Knox
Journal:  Transl Res       Date:  2016-07-18       Impact factor: 7.012

2.  Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans.

Authors:  Krishanthi Subramaniam; Neil French; Liise-Anne Pirofski
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

3.  C3b/iC3b deposition on Streptococcus pneumoniae is not affected by HIV infection.

Authors:  Catherine Hyams; Jerry C H Tam; Jeremy S Brown; Stephen B Gordon
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

Review 4.  Impact of antiretroviral therapy on lung immunology and inflammation.

Authors:  Homer L Twigg; Kenneth S Knox
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

5.  HIV-Related Lung Disorders.

Authors:  Homer L Twigg; Kenneth S Knox
Journal:  Drug Discov Today Dis Mech       Date:  2007

6.  COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.

Authors:  Ildefonso Sánchez-Cerrillo; Pedro Landete; Beatriz Aldave; Santiago Sánchez-Alonso; Ana Sánchez-Azofra; Ana Marcos-Jiménez; Elena Ávalos; Ana Alcaraz-Serna; Ignacio de Los Santos; Tamara Mateu-Albero; Laura Esparcia; Celia López-Sanz; Pedro Martínez-Fleta; Ligia Gabrie; Luciana Del Campo Guerola; Hortensia de la Fuente; María J Calzada; Isidoro González-Álvaro; Arantzazu Alfranca; Francisco Sánchez-Madrid; Cecilia Muñoz-Calleja; Joan B Soriano; Julio Ancochea; Enrique Martín-Gayo
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

7.  Pneumococcal conjugate vaccine is immunogenic in lung fluid of HIV-infected and immunocompetent adults.

Authors:  Stephen B Gordon; Helena Kayhty; Malcolm E Molyneux; Raili Haikala; Anu Nurkka; Janelisa Musaya; Eduard E Zijlstra; Dennis Lindell; Neil French
Journal:  J Allergy Clin Immunol       Date:  2007-06-04       Impact factor: 10.793

8.  Differences in Homing Potentials of Streptococcus pneumoniae-Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations.

Authors:  Nina V Palkola; Sari H Pakkanen; Jussi M Kantele; Laura Pakarinen; Ritvaleena Puohiniemi; Anu Kantele
Journal:  J Infect Dis       Date:  2015-04-02       Impact factor: 5.226

9.  Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses.

Authors:  Stephen B Gordon; Rose Malamba; Neema Mthunthama; Elizabeth R Jarman; Kondwani Jambo; Khuzwayo Jere; Eduard E Zijlstra; Malcolm E Molyneux; John Dennis; Neil French
Journal:  Vaccine       Date:  2008-08-15       Impact factor: 3.641

10.  Increased IgG but normal IgA anti-pneumococcal protein antibodies in lung of HIV-infected adults.

Authors:  Andrea M Collins; Sherouk El Batrawy; Stephen B Gordon; Daniela M Ferreira
Journal:  Vaccine       Date:  2013-05-10       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.